Vertex Pharmaceuticals (VRTX) Acquisitions (2009 - 2019)
Vertex Pharmaceuticals (VRTX) posted quarterly Acquisitions of $908.4 million for Q4 2019, up 939.07% quarter-over-quarter from $87.4 million in Q1 2009.
Powered by 
Analysis
Vertex Pharmaceuticals (VRTX) Acquisitions (2009 - 2019) Analysis & Trends
Vertex Pharmaceuticals' Acquisitions history runs 2 years deep, the most recent figure standing at $908.4 million for Q4 2019.
- In Q4 2019, Acquisitions changed N/A year-over-year to $908.4 million; the TTM figure through Dec 2022 stood at $908.4 million (changed 0.0% YoY), while the FY2022 annual figure was $295.9 million, changed N/A from the prior year.
- Acquisitions for Q4 2019 stood at $908.4 million, up from $87.4 million in the prior quarter.
- The five-year high for Acquisitions was $908.4 million in Q4 2019, with the low at $908.4 million in Q4 2019.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.22 Bn | 132.37 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.04 Bn | 78.05 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.70 Bn | 58.52 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.56 Bn | 52.42 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.05 Bn | 44.05 Bn | - | - |
| 6 | BeOne Medicines | 40.16 Bn | 35.06 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.63 Bn | 32.32 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.63 Bn | 27.79 Bn | - | - |
| 9 | Insmed | 27.73 Bn | 26.57 Bn | 358.27 Mn | - |
| 10 | Incyte | 25.60 Bn | 21.07 Bn | 1.57 Bn | - |